Novel brain PET imaging agents: Strategies for imaging neuroinflammation in Alzheimer’s disease and mild cognitive impairment

Alzheimer’s disease (AD) is a devastating neurodegenerative disease with a concealed onset and continuous deterioration. Mild cognitive impairment (MCI) is the prodromal stage of AD. Molecule-based imaging with positron emission tomography (PET) is critical in tracking pathophysiological changes amo...

Descripción completa

Detalles Bibliográficos
Autor principal: Huang, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537554/
https://www.ncbi.nlm.nih.gov/pubmed/36211392
http://dx.doi.org/10.3389/fimmu.2022.1010946

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9537554/
https://www.ncbi.nlm.nih.gov/pubmed/36211392
http://dx.doi.org/10.3389/fimmu.2022.1010946

Ejemplares similares